Cryofocus Medtech (Shanghai) Co. Ltd. Class H (HK:6922) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cryofocus Medtech (Shanghai) Co., Ltd. has successfully completed the conversion of its unlisted shares into H shares, which will be listed for trading on the Stock Exchange starting September 6, 2024. This move changes the company’s shareholding structure, increasing the proportion of H shares to approximately 60% of the total share capital. Shareholders are advised to exercise caution when dealing in the company’s securities.
For further insights into HK:6922 stock, check out TipRanks’ Stock Analysis page.